| 摘要 |
<p>The present invention relates to a methods of (a) inhibiting angiogenesis in mammal or (b) treating or preventing a disease or condition that is caused or mediated by angiogenesis or of which angiogenesis is a symptom in a mammal, using compounds that are substance P receptor antagonists and, specifically, certain quinuclidine derivatives, piperidine derivatives, pyrrolidine derivatives, azanorbornane derivatives, ethylene diamine derivatives and related compounds.</p> |
